Skip to main navigation Skip to search Skip to main content

Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (Intensive Care Medicine, (2022), 48, 12, (1736-1750), 10.1007/s00134-022-06912-w)

  • STARRT-AKI Investigators
  • Department of Medicine and Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada
  • University of Toronto
  • Monash University
  • University of Melbourne
  • Hospital Israelita Albert Einstein
  • Western University
  • Southeast University, Nanjing
  • Chinese Academy of Medical Sciences
  • University of New South Wales
  • Faculty of Medicine and Health

Research output: Contribution to journalComment/Letter to the editorAcademic

11 Downloads (Pure)

Abstract

In the original version of this article, the given and family names of several of the STARRT-AKI Investigators listed in the Acknowledgements section were incorrectly structured. The correct Acknowledgements section is given below. The original article has been corrected. The authors apologize for the mistake.

Original languageEnglish
Pages (from-to)381-383
Number of pages3
JournalIntensive care medicine
Volume49
Issue number3
DOIs
Publication statusPublished - 1 Mar 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (Intensive Care Medicine, (2022), 48, 12, (1736-1750), 10.1007/s00134-022-06912-w)'. Together they form a unique fingerprint.

Cite this